Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Inactivated Subunit Influenza Vaccine Grippol ® Quadri and Trivalent Inactivated Polymer-Subunit Vaccine Grippol® Plus in Volunteers

Condition:   Influenza Interventions:   Biological: Grippol® Quadri;   Biological: Grippol® Plus, trivalent (Yamagata lineage);   Biological: Grippol® Plus, trivalent (Victoria lineage) Sponsor:   NPO Petrovax Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials